Inhibition of methionine uptake by cis-diamminedichloroplatinum (II) in experimental brain tumors

International Journal of Cancer

Volumn 67, Issue 5, 1996, Pages 681-683

  Mineura, Katsuyoshi ^a   Sasajima, Toshio ^a   Sasajima, Hiroyasu ^a   Kowada, Masayoshi ^a  

^a AKITA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; METHIONINE;

AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TUMOR; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ABSORPTION; ANIMALS; ANTINEOPLASTIC AGENTS; AUTORADIOGRAPHY; BIOLOGICAL TRANSPORT; BRAIN NEOPLASMS; CISPLATIN; HYDROGEN-ION CONCENTRATION; KINETICS; MALE; METHIONINE; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY; TUMOR CELLS, CULTURED;

EID: 0029777429     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960904)67:5<681::AID-IJC15>3.0.CO;2-8     Document Type: Article

References (19)

1. BENDA, P., LIGHTBODY, J., SATO, G., LEVINE, L. and SWEET, W., Differentiated rat glial-cell strain in tissue culture. Science, 161, 370-371 (1968).
2. BUSWELL, L., RECHT, A., CLARK, J., PAVIKUMAR, T., BUSSE, P.M. and COLEMAN, C.N., Combined-modality therapy of esophageal cancer with radiotherapy, etanidazole and cisplatin-fluorouracil, with or without surgery: neurotoxicity, other toxicities and outcome. Int. J. Radiat. Oncol. Biol. Phys., 29, 535-540 (1994).
3. 11C]L-methionine uptake in gliomas. Neurosurgery, 25, 720-728 (1989).
4. FORASTIERE, A.A., Cisplatin and radiotherapy in the management of locally advanced head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys., 27, 465-470 (1993).
5. GOSEKI, N., YAMAZAKI, S., SHIMOJYU, K., KANDO, F., MARUYAMA, M., ENDO, M., KOIKE, M. and TAKAHASHI, H., Synergistic effect of methionine-depleting total parenteral nutrition with 5-fluorouracil on human gastric cancer: a randomized, prospective clinical trial. Jap. J. Cancer Res., 86, 484-489 (1995).
6. HOSHIYA, Y., GUO, H., KUBOTA, T., INADA, T., ASANUMA, F., YAMADA, Y., KOH, J., KITAJIMA, M. and HOFFMAN, R.M., Human tumors are methionine-dependent in vivo. Anticancer Res., 15, 717-718 (1995).
7. 11C]methionine. Int. J. Radiat. Oncol. Biol. Phys., 32, 787-794 (1995).
8. MAHALEY, M.S., Neuro-oncology index and review (adult primary brain tumors). J. Neurooncol., 11, 85-147 (1991).
9. 14C-methyl-1:4-naphthohydroquinone diphosphate. Brit. J. Cancer, 10, 575-582 (1956).
10. 6-MT) activity and cellular resistance to anti-tumor nitrosoureas in cultured rat-brain-tumor cell strains. Acta neurochir. (Wien), 103, 62-66 (1990).
11. MINEURA, K. and KOWADA, M., Enhancement of 5-fluorouracil cytotoxicity by cisplatin in brain-tumor cells. Cell Biol. Int. (1996). (In press).
12. 6-metnylguanine-DNA-methyltransferase activity as an index of drug responsiveness to anti-tumor chloroethylnitrosoureas in xenografted brain tumors. In: K. Tabuchi (ed.), Biological aspects of brain tumors, pp. 266-272, Springer, Tokyo (1991).
13. 14C-methyl)-L-methionine uptake in rat brain tumors before and after treatment with the protein-synthesis inhibitor cycloheximide. J. Neurooncol., 15, 229-233 (1993).
14. OLDENDORF, W.H., Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. Amer. J. Physiol., 221, 1629-1639 (1971).
15. SCANLON, K.J. and KASHANI-SABET, M., Elevated expression of thymidylate-synthase-cycle genes in cisplatin-resistant human ovarian-carcinoma A2780 cells. Proc. nat. Acad. Sci. (Wash.), 85, 650-653 (1988).
16. SCANLON, K.J., NEWMAN, E.M., LU, Y. and PRIEST, D.G., Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian-carcinoma cells. Proc. nat. Acad. Sci. (Wash.), 83, 8923-8925 (1986).
17. SHANI, J. and WOLF, W., Modalities of cisplatin administration to brain tumors. Cancer Invest., 7, 571-579 (1989).
18. SHIRASAKA, T., SHIMAMOTO, Y., OHSHIMO, H., SAITO, H. and FUKUSHIMA, M., Metabolic basis of the synergistic anti-tumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo. Cancer Chemother. Pharmacol., 32, 167-172 (1993).
19. SPENCE, A.M., BERGER, M.S., LIVINGSTON, R.B., ALI-OSMAN, F. and GRIFFIN, B., Phase-II evaluation of high-dose intravenous cisplatin for treatment of adult malignant gliomas recurrent after chloroethylnitrosourea failure. J. Neurooncol., 12, 187-191 (1992).